REST is a novel prognostic factor and therapeutic target for medulloblastoma

Pete Taylor, Jason Fangusaro*, Veena Rajaram, Stewart Goldman, Irene B. Helenowski, Tobey MacDonald, Martin Hasselblatt, Lars Riedemann, Alvaro Laureano, Laurence Cooper, Vidya Gopalakrishnan

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

46 Scopus citations

Fingerprint

Dive into the research topics of 'REST is a novel prognostic factor and therapeutic target for medulloblastoma'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

INIS

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology

Neuroscience